Clinical Trial

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

Study acronym: HASD_PIB_IND
Recruiting
View on ClinicalTrials.gov →
Summary
To identify factors that signal the transition from asymptomatic (preclinical) to symptomatic Alzheimer disease (AD).
Trial Details
NCT Number NCT04579120
Lead Sponsor Tammie L. S. Benzinger, MD, PhD
Conditions Alzheimer Disease
Enrollment 650 participants
Start Date 2021-09-01
Primary Completion 2027-11 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-08